Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Colon Cancer Immunotherapy
Reports on colon cancer immunotherapy findings from Wistar Institute provide new insights
March 2nd, 2007
New investigation results, "Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture," are detailed in a study published in Cancer Immunology, Immunotherapy. According to a study from the United States, "Adoptive immunotherapy of cancer patients with cytolytic T lymphocytes (CTL) has been hampered by the inability of the CTL to home into tumors in vivo. Chemokines can attract T lymphocytes to the tumor site, as demonstrated in animal models, but the role of chemokines in T-lymphocyte trafficking toward human tumor cells is relatively unexplored." "In the present study, the role of chemokines and their...
Source: Drug Week (2007-03-02)
|
